Gestalt (Decision/Risk Analysis) Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 34

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $7.5M

  • Investors
  • 15

Gestalt (Decision/Risk Analysis) General Information

Description

Developer of a software platform designed to bring the benefits of digital workflow to pathologists and pathology laboratories. The company provides digital pathology using advanced technology, proven digital expertise, and artificial intelligence, enabling pathologists to diagnose diseases faster and more efficiently.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 850 East Spokane Falls Boulevard
  • Suite 135
  • Spokane, WA 99202
  • United States
+1 (509)
Primary Industry
Decision/Risk Analysis
Corporate Office
  • 850 East Spokane Falls Boulevard
  • Suite 135
  • Spokane, WA 99202
  • United States
+1 (509)

Gestalt (Decision/Risk Analysis) Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gestalt (Decision/Risk Analysis) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A) 28-Apr-2025 $7.5M Completed Generating Revenue
5. Grant 29-Apr-2024 Completed Generating Revenue
4. Seed Round 15-Apr-2021 Completed Generating Revenue
3. Debt - PPP 11-Apr-2020 Completed Generating Revenue
2. Seed Round 16-Mar-2017 $2.75M $2.75M Completed Generating Revenue
1. Joint Venture 01-Jan-2015 $500K Completed Startup
To view Gestalt (Decision/Risk Analysis)’s complete valuation and funding history, request access »

Gestalt (Decision/Risk Analysis) Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed-2
Seed-1 3,243,000 $0.000100 $1 $1 1x $1 11.77%
To view Gestalt (Decision/Risk Analysis)’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Gestalt (Decision/Risk Analysis) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a software platform designed to bring the benefits of digital workflow to pathologists and pathology labora
Decision/Risk Analysis
Spokane, WA
34 As of 2026

Seoul, South Korea
 

Tel Aviv, Israel
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Gestalt (Decision/Risk Analysis) Competitors (6)

One of Gestalt (Decision/Risk Analysis)’s 6 competitors is Deep Bio, a Venture Capital-Backed company based in Seoul, South Korea.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Deep Bio Venture Capital-Backed Seoul, South Korea
Ibex Medical Analytics Venture Capital-Backed Tel Aviv, Israel
Paige Formerly VC-backed New York, NY
Techcyte Venture Capital-Backed Orem, UT
Proscia Formerly VC-backed Philadelphia, PA
To view Gestalt (Decision/Risk Analysis)’s complete competitors history, request access »

Gestalt (Decision/Risk Analysis) Patents

Gestalt (Decision/Risk Analysis) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-D1113948-S1 Display screen or portion thereof with an animated graphical user interface Active 15-Mar-2024
EP-4276846-A1 Enhanced digital pathology platform Pending 10-May-2022
GB-202306821-D0 Enhanced digital pathology platform Pending 10-May-2022
GB-2620669-A Enhanced digital pathology platform Pending 10-May-2022
US-12272026-B2 Enhanced digital pathology platform Active 10-May-2022 G06T5/50
To view Gestalt (Decision/Risk Analysis)’s complete patent history, request access »

Gestalt (Decision/Risk Analysis) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gestalt (Decision/Risk Analysis) Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
TechVision Fund Venture Capital Minority
Health Sciences & Services Authority of Spokane County Government
Believe in Me Foundation Corporation Minority
Puget Sound Venture Club Angel Group Minority
Sun Mountain Capital Venture Capital Minority
You’re viewing 5 of 15 investors. Get the full list »

Gestalt (Decision/Risk Analysis) Acquisitions (1)

Gestalt (Decision/Risk Analysis)’s most recent deal was a Merger/Acquisition with Peak Medical Technologies. The deal was made on 04-Feb-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Peak Medical Technologies 04-Feb-2019 Merger/Acquisition Enterprise Systems (Healthcare)
To view Gestalt (Decision/Risk Analysis)’s complete acquisitions history, request access »

Gestalt (Decision/Risk Analysis) FAQs

  • When was Gestalt (Decision/Risk Analysis) founded?

    Gestalt (Decision/Risk Analysis) was founded in 2015.

  • Where is Gestalt (Decision/Risk Analysis) headquartered?

    Gestalt (Decision/Risk Analysis) is headquartered in Spokane, WA.

  • What is the size of Gestalt (Decision/Risk Analysis)?

    Gestalt (Decision/Risk Analysis) has 34 total employees.

  • What industry is Gestalt (Decision/Risk Analysis) in?

    Gestalt (Decision/Risk Analysis)’s primary industry is Decision/Risk Analysis.

  • Is Gestalt (Decision/Risk Analysis) a private or public company?

    Gestalt (Decision/Risk Analysis) is a Private company.

  • What is the current valuation of Gestalt (Decision/Risk Analysis)?

    The current valuation of Gestalt (Decision/Risk Analysis) is .

  • What is Gestalt (Decision/Risk Analysis)’s current revenue?

    The current revenue for Gestalt (Decision/Risk Analysis) is .

  • How much funding has Gestalt (Decision/Risk Analysis) raised over time?

    Gestalt (Decision/Risk Analysis) has raised $14.1M.

  • Who are Gestalt (Decision/Risk Analysis)’s investors?

    TechVision Fund, Health Sciences & Services Authority of Spokane County, Believe in Me Foundation, Puget Sound Venture Club, and Sun Mountain Capital are 5 of 15 investors who have invested in Gestalt (Decision/Risk Analysis).

  • Who are Gestalt (Decision/Risk Analysis)’s competitors?

    Deep Bio, Ibex Medical Analytics, Paige, Techcyte, and Proscia are some of the 6 competitors of Gestalt (Decision/Risk Analysis).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process